• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[粪便移植:未来的疗法?]

[Fecal transplantation the future therapy?].

作者信息

Rebizak Ewelina, Sierant Katarzyna, Łabuzek Krzysztof, Okopień Bogusław

机构信息

Department of Internal Diseases and Clinical Pharmacology, Silesian.

出版信息

Pol Merkur Lekarski. 2015 Aug;39(230):73-6.

PMID:26319378
Abstract

Intestinal bacteria play an important role in human physiology, taking part in the metabolism, absorption of nutrients and regulation of the immune system. In many illnesses the bacterial imbalance in the digestive tract occurs, and fecal transplantation is one method that allows you to restore the balance. The essence of the described method is to replace the pathogenesis, abnormal bacterial flora with the flora occurring in normal healthy individuals. So far, the main use of the method described in the article is resistant to antibiotics Clostridium difficile infection, which gives you a chance to avoid total colectomy. The article presents an accurate description of the same procedure to prepare the material, the selection of donor, recipient preparation and diseases, such as inflammatory bowel diseases, irritable bowel syndrome, diabetes and obesity, in which this method of treatment is currently practised.

摘要

肠道细菌在人体生理机能中发挥着重要作用,参与新陈代谢、营养吸收以及免疫系统调节。在许多疾病中,消化道会出现细菌失衡的情况,而粪便移植是一种能够恢复平衡的方法。所述方法的本质是用正常健康个体体内的菌群替代致病的、异常的细菌菌群。到目前为止,本文所述方法的主要用途是治疗对抗生素耐药的艰难梭菌感染,这使人们有机会避免进行全结肠切除术。本文准确描述了该治疗方法的相同步骤,包括材料准备、供体选择、受体准备以及目前正在采用这种治疗方法的疾病,如炎症性肠病、肠易激综合征、糖尿病和肥胖症。

相似文献

1
[Fecal transplantation the future therapy?].[粪便移植:未来的疗法?]
Pol Merkur Lekarski. 2015 Aug;39(230):73-6.
2
An overview of fecal microbiota transplantation: techniques, indications, and outcomes.粪便微生物群移植概述:技术、适应症及结果
Gastrointest Endosc. 2013 Aug;78(2):240-9. doi: 10.1016/j.gie.2013.03.1329. Epub 2013 May 2.
3
Fecal microbiota transplantation: past, present and future.粪便微生物移植:过去、现在和未来。
Curr Opin Gastroenterol. 2013 Jan;29(1):79-84. doi: 10.1097/MOG.0b013e32835a4b3e.
4
Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.肠道微生物组的改变:粪便微生物群移植和益生菌治疗艰难梭菌感染及其他疾病。
Expert Rev Gastroenterol Hepatol. 2013 Sep;7(7):615-28. doi: 10.1586/17474124.2013.832501.
5
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.粪便微生物群移植治疗合并炎症性肠病的复发性艰难梭菌感染患者
Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016.
6
Therapeutic potential of fecal microbiota transplantation.粪便微生物群移植的治疗潜力。
Gastroenterology. 2013 Nov;145(5):946-53. doi: 10.1053/j.gastro.2013.08.058. Epub 2013 Sep 7.
7
Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update.粪便微生物群移植治疗儿童难治性艰难梭菌感染:最新进展
Curr Opin Pediatr. 2014 Oct;26(5):573-8. doi: 10.1097/MOP.0000000000000127.
8
Fecal microbiota transplantation: indications, methods, evidence, and future directions.粪便微生物群移植:适应症、方法、证据及未来方向。
Curr Gastroenterol Rep. 2013 Aug;15(8):337. doi: 10.1007/s11894-013-0337-1.
9
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.肠道微生物群发病机制及粪便微生物群移植治疗炎症性肠病
World J Gastroenterol. 2014 Oct 28;20(40):14805-20. doi: 10.3748/wjg.v20.i40.14805.
10
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?粪便微生物移植在肠道疾病以外有潜在的应用吗?
Biomed Res Int. 2019 Jul 29;2019:3469754. doi: 10.1155/2019/3469754. eCollection 2019.

引用本文的文献

1
Obesity: pathophysiology and therapeutic interventions.肥胖症:病理生理学与治疗干预措施
Mol Biomed. 2025 Apr 25;6(1):25. doi: 10.1186/s43556-025-00264-9.
2
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.5-羟色胺转运体在肠易激综合征发病机制中的调节作用
World J Gastroenterol. 2016 Sep 28;22(36):8137-48. doi: 10.3748/wjg.v22.i36.8137.